Trailing-twelve-month (TTM) revenue is $3.31 Billion with a year-over-year growth of +9.41%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q4 FY2025Period ended 2025-09-30 | $810,090,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-25 |
| Q1 FY2026Period ended 2025-12-31 | $822,465,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-05 |
| Q2 FY2026Period ended 2026-03-31 | $811,700,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-05 |
| Q3 FY2026Period ended 2026-06-30 | $865,077,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-06 |
| TTM revenue | $3,309,332,000 |
Current P/S: $23,228,348,832 market capitalization ÷ $3,309,332,000 TTM revenue = 7.02x.
Market capitalization source: FMP quote. Quote observed 2026-09-11T20:00:01.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q3 FY2026 (2026-06-30): $865.08M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-09-12T00:15:31.812Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-10.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-09-30 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-09-30 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-09-30 · USD | FY20212021-09-30 · USD | FY20222022-09-30 · USD | FY20232023-09-30 · USD | FY20242024-09-30 · USD | FY20252025-09-30 · USD |
|---|---|---|---|---|---|---|
| Product | $1.0B | $1.2B | $1.3B | $1.3B | $1.3B | $1.5B |
| Service | $1.3B | $1.4B | $1.4B | $1.5B |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-09-30 · USD | FY20212021-09-30 · USD | FY20222022-09-30 · USD | FY20232023-09-30 · USD | FY20242024-09-30 · USD | FY20252025-09-30 · USD |
|---|---|---|---|---|---|---|
| Americas | $1.3B | $1.5B | $1.6B | $1.6B | $1.6B | $1.7B |
| Asia Pacific | $440M | $478M | $488M | $487M |
$3.31B
$3.31 Billion
+9.41%
vs. $3.02B a year ago (TTM)
+5.47%
5 Year compound annual growth rate
1 Year
+9.41%
3 Year
+5.65%
5 Year
+5.47%
10 Year
+5.32%
15 Year
+7.67%
20 Year
+11.69%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $3.09B | +$271.95M | +9.66% |
| 2024 | $2.82B | +$2.95M | +0.10% |
| 2023 | $2.81B | +$117.32M | +4.35% |
| 2022 | $2.70B | +$92.43M | +3.55% |
| 2021 | $2.60B | +$252.59M | +10.74% |
| 2020 |
TTM Growth
+9.41%
3-Year CAGR
+5.65%
5-Year CAGR
+5.47%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-09-12T00:15:31.812Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-10.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $1.5B |
| $1.6B |
| $537M |
| EMEA | $593M | $667M | $635M | $742M | $756M | $827M |
|---|
| $2.35B |
| +$108.38M |
| +4.83% |
| 2019 | $2.24B | +$81.04M | +3.75% |
| 2018 | $2.16B | +$71.37M | +3.41% |
| 2017 | $2.09B | +$95.01M | +4.76% |
| 2016 | $2.00B | +$75.21M | +3.92% |
